Who owns First Trust Nasdaq Pharmaceuticals ETF?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of FTXH from SEC Form 13F filings across 31 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 31 institutions disclosed 618,699 shares of First Trust Nasdaq Pharmaceuticals ETF worth $22.5M — about 2.5% of shares outstanding; the largest disclosed holder is LPL Financial LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
31
13F holders
$22.5M
value, 2026 filers
2.5%
of shares outstanding (618,699 sh)
3
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of FTXH's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | LPL Financial LLC | 151,471 | $5.8M | 0.0% | 0.6% | -14.7% |
| 2 | OPPENHEIMER & CO INC | 114,183 | $4.4M | 0.0% | 0.5% | +181.6% |
| 3 | RAYMOND JAMES FINANCIAL INC | 54,968 | $2.1M | 0.0% | 0.2% | +369.1% |
| 4 | TRUIST FINANCIAL CORP | 52,126 | $2.0M | 0.0% | 0.2% | -8.7% |
| 5 | MARSHALL INVESTMENT MANAGEMENT, LLC | 38,080 | $1.5M | 0.6% | 0.2% | -15.8% |
| 6 | Ameritas Investment Partners, Inc. | 33,987 | $1.3M | 0.0% | 0.1% | +13.0% |
| 7 | Cambridge Investment Research Advisors, Inc. | 30,525 | $1,166 | 0.0% | 0.1% | +56.2% |
| 8 | Nilsine Partners, LLC | 28,057 | $1.1M | 0.1% | 0.1% | +3.5% |
| 9 | ROYAL BANK OF CANADA | 14,322 | $547,000 | 0.0% | 0.1% | +28544.0% |
| 10 | GOLDMAN SACHS GROUP INC | 13,730 | $524,345 | 0.0% | 0.1% | -29.1% |
| 11 | COMMONWEALTH EQUITY SERVICES, LLC | 10,734 | $409,910 | 0.0% | 0% | +49.3% |
| 12 | OneDigital Investment Advisors LLC | 9,325 | $356,119 | 0.0% | 0% | 0.0% |
| 13 | Sound Income Strategies, LLC | 8,627 | $329,463 | 0.0% | 0% | 0.0% |
| 14 | ENVESTNET ASSET MANAGEMENT INC | 8,340 | $318,504 | 0.0% | 0% | -52.6% |
| 15 | Stratos Wealth Partners, LTD. | 8,180 | $312,392 | 0.0% | 0% | +9.3% |
| 16 | BETO FINANCIAL GROUP, LLC | 6,833 | $259,848 | 0.1% | 0% | 0.0% |
| 17 | CITADEL ADVISORS LLC | 6,822 | $260,530 | 0.0% | 0% | -33.5% |
| 18 | MORGAN STANLEY | 5,917 | $225,984 | 0.0% | 0% | 0.0% |
| 19 | FLAGSHIP HARBOR ADVISORS, LLC | 5,632 | $215,085 | 0.0% | 0% | -12.3% |
| 20 | INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLCNEW | 4,421 | $168,499 | 0.0% | 0% | new |
| 21 | BANK OF MONTREAL /CAN/ | 4,326 | $165,208 | 0.0% | 0% | -53.0% |
| 22 | OSAIC HOLDINGS, INC. | 2,556 | $97,642 | 0.0% | 0% | +45.1% |
| 23 | LANARK FINANCIAL, INC. | 1,162 | $44,376 | 0.0% | 0% | -12.1% |
| 24 | Steward Partners Investment Advisory, LLC | 1,046 | $39,946 | 0.0% | 0% | 0.0% |
| 25 | HARBOUR INVESTMENTS, INC. | 929 | $35,478 | 0.0% | 0% | +11.1% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.